Contineum Therapeutics, Inc. Price to FCF Ratio 2024–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Price to free cash flow (P/FCF) ratio for Contineum Therapeutics, Inc. (CTNM): market cap divided by trailing twelve-month free cash flow. As of September 30, 2024 it is 26.01.

From: 09/30/2024To: 09/30/2024

Stock Price

TTM Free Cash Flow

Price to FCF

Contineum Therapeutics, Inc. Price to FCF Ratio — FAQ

Contineum Therapeutics, Inc. (CTNM) price to fcf ratio over the last 2 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CTNM's price to fcf ratio history?

The chart and table above show Contineum Therapeutics, Inc.'s price to fcf ratio by year and by quarter, including the growth rate.